Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cortico-juxtacortical involvement increases risk of epileptic seizures in multiple sclerosis.
Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes.
Cell intrinsic role of NF-κB-inducing kinase in regulating T cell-mediated immune and autoimmune responses.
Development and assessment of a website presenting evidence-based information for people with multiple sclerosis: the IN-DEEP project.
Multiple sclerosis: genetics, biomarkers, treatments.
Venocentric Lesions: An MRI Marker of MS?
The influence of tetracyclines on T cell activation.
Effect of Multiple Infusions of AIN457 on Disease Activity in Relapsing-remitting Multiple Sclerosis
Motivational interviewing may improve exercise experience for people with multiple sclerosis: A small randomized trial.
Review: the role of vitamin D in nervous system health and disease.
Human T cell expansion and experimental autoimmune encephalomyelitis inhibited by Lenaldekar, a small molecule discovered in a zebrafish screen.
FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS
UCSF Neuroimmunology Research Seminar
[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain].
Longitudinal Penalized Functional Regression for Cognitive Outcomes on Neuronal Tract Measurements.
Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and upregulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.
The role of regulatory T cells in neurodegenerative diseases.
Interleukin-17- and interleukin-22-secreting myelin-specific CD4(+) T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients.
Low dose naltrexone for induction of remission in Crohn's disease.
Multiple sclerosis reactivation postfingolimod cessation: Is it IRIS?
Cost-effectiveness of early initiation of fingolimod versus delayed initiation after 1 year of intramuscular interferon Beta-1a in patients with multiple sclerosis.
Evidence that nuclear factor IA inhibits repair after white matter injury.
Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes.
A comparative study of CSF neurofilament light and heavy chain protein in MS.
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.

Pages